A systematic review of cost-effectiveness analyses of biological DMARDs in rheumatoid arthritis

被引：0
|
作者：
Richard, L. [1 ]
Brown, M. [2 ]
机构：
[1] UCB Celltech, Slough, Berks, England
[2] UCB, Slough, Berks, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)64924-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A245 / A246
页数：2
相关论文
共 50 条
  • [1] The cost-effectiveness of biological drugs for rheumatoid arthritis: a systematic review
    Joensuu, J. T.
    Aaltonen, K. J.
    Nordstrom, D.
    Konttinen, Y. T.
    Blom, M.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (05) : 434 - 435
  • [2] COMBINATION DMARDS FOR RHEUMATOID ARTHRITIS: A COST-EFFECTIVENESS ANALYSIS
    Tosh, Jonathan
    Wailoo, Allan
    [J]. RHEUMATOLOGY, 2009, 48 : I68 - I69
  • [3] Cost-effectiveness analyses of TNF antagonists in rheumatoid arthritis: A review
    Bansback, N
    Regier, D
    Ara, R
    Brenan, A
    Shojania, K
    Esdaile, J
    Anis, A
    Marra, C
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S510 - S510
  • [4] SYSTEMATIC LITERATURE REVIEW: BIOLOGICAL DMARDS IN RHEUMATOID ARTHRITIS
    Nam, J. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 43 - 43
  • [5] The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review
    Joensuu, Jaana T.
    Huoponen, Saara
    Aaltonen, Kalle J.
    Konttinen, Yrjo T.
    Nordstrom, Dan
    Blom, Marja
    [J]. PLOS ONE, 2015, 10 (03):
  • [6] THE COST-EFFECTIVENESS OF BIOLOGIS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW
    Joensuu, J. T.
    Aaltonen, K. J.
    Huoponen, S.
    Konttinen, Y. T.
    Nordstrom, D.
    Blom, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 451 - 452
  • [7] Assessing cost-effectiveness analyses in rheumatoid arthritis and osteoarthritis
    Ruchlin, HS
    Elkin, EB
    Paget, SA
    [J]. ARTHRITIS CARE & RESEARCH, 1997, 10 (06) : 413 - 421
  • [8] The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
    Wailoo, Allan
    Hock, Emma S.
    Stevenson, Matt
    Martyn-St James, Marrissa
    Rawdin, Andrew
    Simpson, Emma
    Wong, Ruth
    Dracup, Naila
    Scott, David L.
    Young, Adam
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (71) : 1 - +
  • [9] A cost-effectiveness analysis of biological treatments for rheumatoid arthritis
    Chiou, CF
    Wanke, L
    Yu, E
    Ofman, J
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 223 - 223
  • [10] A REVIEW OF COST-EFFECTIVENESS EVALUATIONS AS PART OF NATIONAL HTA ASSESSMENTS OF BIOLOGIC DMARDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Iannazzo, S.
    De Francesco, M.
    Gomez-Ulloa, D.
    Benucci, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A571 - A571
12345